Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases

Shastri, MD Allam, VSRR Shukla, SD Jha, NK Paudel, KR Peterson, GM Patel, RP Hansbro, PM Chellappan, DK Dua, K

Permalink

Open Access

Copyright Clearance Process

This item is open access.

The embargo period expires on 2 Aug 2022

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Shastri, MD
dc.contributor.author	Allam, VSRR
dc.contributor.author	Shukla, SD
dc.contributor.author	Jha, NK
dc.contributor.author	Paudel, KR
dc.contributor.author	Peterson, GM
dc.contributor.author	Patel, RP
dc.contributor.author	Hansbro, PM
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dua, K
dc.date.accessioned	2021-08-03T23:07:14Z
dc.date.available	2021-08-03T23:07:14Z
dc.date.issued	2021-08
dc.identifier.citation	Life Sciences, 2021, pp. 119871-119871
dc.identifier.issn	0024-3205
dc.identifier.uri	http://hdl.handle.net/10453/150031
dc.language	en
dc.publisher	Elsevier BV
dc.relation.ispartof	Life Sciences
dc.relation.isbasedon	10.1016/j.lfs.2021.119871
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.subject	0601 Biochemistry and Cell Biology, 1115 Pharmacology and Pharmaceutical Sciences
dc.subject.classification	Pharmacology & Pharmacy
dc.title	Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases
dc.type	Journal Article
utslib.for	0601 Biochemistry and Cell Biology
utslib.for	1115 Pharmacology and Pharmaceutical Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	open_access	*
utslib.copyright.embargo	2022-08-02T00:00:00+1000Z
dc.date.updated	2021-08-03T23:07:13Z
pubs.publication-status	Published

Please use this identifier to cite or link to this item: